Aster Capital Management (Difc) LTD Summit Therapeutics Inc. Transaction History
Aster Capital Management (Difc) LTD
- $441 Billion
- Q2 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 1,425 shares of SMMT stock, worth $31,065. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,425
Previous 32,509
95.62%
Holding current value
$31,065
Previous $673 Million
95.49%
% of portfolio
0.01%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding SMMT
# of Institutions
260Shares Held
90.4MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$735 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$189 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$172 Million0.0% of portfolio
-
State Street Corp Boston, MA4.02MShares$87.6 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$85.1 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.39B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...